Gujarat Themis Biosyn informs about quarterly statement of investor complaints

18 Apr 2016 Evaluate

Gujarat Themis Biosyn has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

385.35 -5.95 (-1.52%)
17-Dec-2025 11:55 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1784.05
Dr. Reddys Lab 1279.00
Cipla 1493.10
Zydus Lifesciences 917.85
Lupin 2113.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×